Stanford-Kaiser Permanente G1 study for clinical stage I to IIA Hodgkin's disease: subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation. (Q50954194)
Jump to navigation
Jump to search
scientific article published in May 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Stanford-Kaiser Permanente G1 study for clinical stage I to IIA Hodgkin's disease: subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation. |
scientific article published in May 1997 |
Statements
1 reference
Stanford-Kaiser Permanente G1 study for clinical stage I to IIA Hodgkin's disease: subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation. (English)
1 reference
R T Hoppe
1 reference
S J Horning
1 reference
J Mason
1 reference
B W Brown
1 reference
S L Hancock
1 reference
D Baer
1 reference
S A Rosenberg
1 reference
1 May 1997
1 reference
15
1 reference
5
1 reference
1736-1744
1 reference
Identifiers
1 reference